Maarten de Rooij1, Bas Israël1, Tristan Barrett2, Francesco Giganti3, Anwar R Padhani4, Valeria Panebianco5, Jonathan Richenberg6, Georg Salomon7, Ivo G Schoots8, Geert Villeirs9, Jochen Walz10, Jelle O Barentsz11. 1. Department of Radiology, Nuclear Medicine, and Anatomy, Radboudumc, Nijmegen, The Netherlands. 2. Department of Radiology, CamPARI Prostate Cancer Group, Addenbrooke's Hospital and University of Cambridge, Cambridge, UK. 3. Department of Radiology, University College London Hospital NHS Foundation Trust, London, UK; Division of Surgery & Interventional Science, University College London, London, UK. 4. Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK. 5. Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy. 6. Department of Imaging, Brighton and Sussex University Hospital NHS Trust, Brighton, UK. 7. Martini Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 8. Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. 9. Department of Radiology, Ghent University Hospital, Ghent, Belgium. 10. Department of Urology, Institute Paoli-Calmettes Cancer Center, Marseille, France. 11. Department of Radiology, Nuclear Medicine, and Anatomy, Radboudumc, Nijmegen, The Netherlands. Electronic address: jelle.barentsz@radboudumc.nl.
Authors: Anwar R Padhani; Ivo G Schoots; Baris Turkbey; Gianluca Giannarini; Jelle O Barentsz Journal: Eur Radiol Date: 2020-11-25 Impact factor: 5.315